Bowed tendon, clinically known as tendinitis, is one of the most common and career-threatening injuries affecting athletic horses, characterized by damage to the flexor tendons of the lower limb. The term bowed tendon derives from the characteristic convex bulging appearance of the injured tendon when viewed from the side, resembling an archer's bow. This condition most commonly involves the superficial digital flexor tendon (SDFT), though the deep digital flexor tendon (DDFT) and suspensory ligament may also sustain similar injuries. Bowed tendons represent a spectrum of damage ranging from mild fiber disruption to complete tendon rupture.
The prevalence of bowed tendons is highest in athletic horses engaged in speed work and jumping, with Thoroughbred racehorses historically showing the greatest incidence. Studies indicate that up to eight to twelve percent of racehorses experience tendon injuries during their careers, representing a leading cause of lost training days and premature retirement. Sport horses in eventing, show jumping, and other disciplines that stress the flexor apparatus also face significant risk. The condition affects forelimbs far more frequently than hindlimbs, reflecting the greater load-bearing responsibilities of the front legs during athletic movement.
The impact of bowed tendon on equine careers and welfare can be devastating, as these injuries often signal the end of high-level competition for affected horses. Tendon tissue heals through scar formation rather than true regeneration, resulting in repaired tissue that is mechanically inferior to original tendon and predisposed to re-injury. Recurrence rates following bowed tendon injuries remain frustratingly high, with some studies reporting re-injury rates of forty to sixty percent in racehorses returning to training. The economic consequences for racing and sport horse industries are substantial, including direct treatment costs, lost training time, reduced sale values, and premature retirements.
Despite the challenging nature of bowed tendon injuries, advances in treatment and rehabilitation have improved outcomes considerably over recent decades. Early recognition allows prompt treatment initiation that may limit injury extent. Modern treatments including regenerative therapies such as stem cells and platelet-rich plasma show promise for improving tissue quality. Structured rehabilitation programs optimize healing while gradually preparing tendons for athletic demands. While many horses cannot return to previous competitive levels, appropriate management enables many to continue in modified activities, and some successfully resume racing or high-level sport. Understanding the condition empowers owners and trainers to make informed decisions about treatment, rehabilitation, and future use.
